165 related articles for article (PubMed ID: 22280363)
1. Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets.
Baud MG; Leiser T; Haus P; Samlal S; Wong AC; Wood RJ; Petrucci V; Gunaratnam M; Hughes SM; Buluwela L; Turlais F; Neidle S; Meyer-Almes FJ; White AJ; Fuchter MJ
J Med Chem; 2012 Feb; 55(4):1731-50. PubMed ID: 22280363
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic profiling of the antitumor natural product psammaplin A and its analogues.
García J; Franci G; Pereira R; Benedetti R; Nebbioso A; Rodríguez-Barrios F; Gronemeyer H; Altucci L; de Lera AR
Bioorg Med Chem; 2011 Jun; 19(12):3637-49. PubMed ID: 21215647
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological evaluation and molecular modeling studies of psammaplin A and its analogs as potent histone deacetylases inhibitors and cytotoxic agents.
Wen J; Bao Y; Niu Q; Liu J; Yang J; Wang W; Jiang T; Fan Y; Li K; Wang J; Zhao L; Liu D
Bioorg Med Chem Lett; 2016 Sep; 26(17):4372-6. PubMed ID: 27460171
[TBL] [Abstract][Full Text] [Related]
4. Psammaplin A is a natural prodrug that inhibits class I histone deacetylase.
Kim DH; Shin J; Kwon HJ
Exp Mol Med; 2007 Feb; 39(1):47-55. PubMed ID: 17334228
[TBL] [Abstract][Full Text] [Related]
5. Efficient synthesis and biological activity of Psammaplin A and its analogues as antitumor agents.
Hong S; Shin Y; Jung M; Ha MW; Park Y; Lee YJ; Shin J; Oh KB; Lee SK; Park HG
Eur J Med Chem; 2015; 96():218-30. PubMed ID: 25884112
[TBL] [Abstract][Full Text] [Related]
6. Camptothecin-psammaplin A hybrids as topoisomerase I and HDAC dual-action inhibitors.
Cincinelli R; Musso L; Artali R; Guglielmi M; Bianchino E; Cardile F; Colelli F; Pisano C; Dallavalle S
Eur J Med Chem; 2018 Jan; 143():2005-2014. PubMed ID: 29150335
[TBL] [Abstract][Full Text] [Related]
7. Highly ligand efficient and selective N-2-(Thioethyl)picolinamide histone deacetylase inhibitors inspired by the natural product psammaplin A.
Baud MG; Haus P; Leiser T; Meyer-Almes FJ; Fuchter MJ
ChemMedChem; 2013 Jan; 8(1):149-56. PubMed ID: 23184734
[TBL] [Abstract][Full Text] [Related]
8. New synthetic strategies towards psammaplin A, access to natural product analogues for biological evaluation.
Baud MG; Leiser T; Meyer-Almes FJ; Fuchter MJ
Org Biomol Chem; 2011 Feb; 9(3):659-62. PubMed ID: 21113514
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and anticancer potential of NSC-319745 hydroxamic acid derivatives as DNMT and HDAC inhibitors.
Yuan Z; Sun Q; Li D; Miao S; Chen S; Song L; Gao C; Chen Y; Tan C; Jiang Y
Eur J Med Chem; 2017 Jul; 134():281-292. PubMed ID: 28419930
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors.
Tavares MT; de Almeida LC; Kronenberger T; Monteiro Ferreira G; Fujii de Divitiis T; Franco Zannini Junqueira Toledo M; Mariko Aymoto Hassimotto N; Agostinho Machado-Neto J; Veras Costa-Lotufo L; Parise-Filho R
Bioorg Med Chem; 2021 Apr; 35():116085. PubMed ID: 33668008
[TBL] [Abstract][Full Text] [Related]
11. Fluorescent analogs of the marine natural product psammaplin A: synthesis and biological activity.
Hentschel F; Sasse F; Lindel T
Org Biomol Chem; 2012 Sep; 10(35):7120-33. PubMed ID: 22872318
[TBL] [Abstract][Full Text] [Related]
12. Indole-derived psammaplin A analogues as epigenetic modulators with multiple inhibitory activities.
Pereira R; Benedetti R; Pérez-Rodríguez S; Nebbioso A; García-Rodríguez J; Carafa V; Stuhldreier M; Conte M; Rodríguez-Barrios F; Stunnenberg HG; Gronemeyer H; Altucci L; de Lera AR
J Med Chem; 2012 Nov; 55(22):9467-91. PubMed ID: 23030799
[TBL] [Abstract][Full Text] [Related]
13. Development of a versatile DNMT and HDAC inhibitor C02S modulating multiple cancer hallmarks for breast cancer therapy.
Yuan Z; Chen S; Gao C; Dai Q; Zhang C; Sun Q; Lin JS; Guo C; Chen Y; Jiang Y
Bioorg Chem; 2019 Jun; 87():200-208. PubMed ID: 30901675
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological activity of NCC149 derivatives as histone deacetylase 8-selective inhibitors.
Suzuki T; Muto N; Bando M; Itoh Y; Masaki A; Ri M; Ota Y; Nakagawa H; Iida S; Shirahige K; Miyata N
ChemMedChem; 2014 Mar; 9(3):657-64. PubMed ID: 24403121
[TBL] [Abstract][Full Text] [Related]
15. Identification of N-(6-mercaptohexyl)-3-(4-pyridyl)-1H-pyrazole-5-carboxamide and its disulfide prodrug as potent histone deacetylase inhibitors with in vitro and in vivo anti-tumor efficacy.
Wen J; Bao Y; Niu Q; Yang J; Fan Y; Li J; Jing Y; Zhao L; Liu D
Eur J Med Chem; 2016 Feb; 109():350-9. PubMed ID: 26814680
[TBL] [Abstract][Full Text] [Related]
16. Discovery of potent, isoform-selective inhibitors of histone deacetylase containing chiral heterocyclic capping groups and a N-(2-aminophenyl)benzamide binding unit.
Marson CM; Matthews CJ; Yiannaki E; Atkinson SJ; Soden PE; Shukla L; Lamadema N; Thomas NS
J Med Chem; 2013 Aug; 56(15):6156-74. PubMed ID: 23829483
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel aminotetralin class of HDAC6 and HDAC8 selective inhibitors.
Tang G; Wong JC; Zhang W; Wang Z; Zhang N; Peng Z; Zhang Z; Rong Y; Li S; Zhang M; Yu L; Feng T; Zhang X; Wu X; Wu JZ; Chen L
J Med Chem; 2014 Oct; 57(19):8026-34. PubMed ID: 25238284
[TBL] [Abstract][Full Text] [Related]
18. An improved synthesis of psammaplin A.
Godert AM; Angelino N; Woloszynska-Read A; Morey SR; James SR; Karpf AR; Sufrin JR
Bioorg Med Chem Lett; 2006 Jun; 16(12):3330-3. PubMed ID: 16632351
[TBL] [Abstract][Full Text] [Related]
19. Design, Multicomponent Synthesis, and Anticancer Activity of a Focused Histone Deacetylase (HDAC) Inhibitor Library with Peptoid-Based Cap Groups.
Krieger V; Hamacher A; Gertzen CGW; Senger J; Zwinderman MRH; Marek M; Romier C; Dekker FJ; Kurz T; Jung M; Gohlke H; Kassack MU; Hansen FK
J Med Chem; 2017 Jul; 60(13):5493-5506. PubMed ID: 28574690
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, Molecular Modeling, and Biological Evaluation of Novel Amine-based Histone Deacetylase Inhibitors.
Abdelkarim H; Neelarapu R; Madriaga A; Vaidya AS; Kastrati I; Karumudi B; Wang YT; Taha TY; Thatcher GRJ; Frasor J; Petukhov PA
ChemMedChem; 2017 Dec; 12(24):2030-2043. PubMed ID: 29080240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
